[1] |
KE Xiuqin, HAI Xuewu.
433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
|
[2] |
ZHAO Yufang, SHI Wei, YANG Shengnan, LIU Zhien, LEI Wenpu, ZHANG Yanan, ZHAO Ke, GUO Hao.
983 Adverse Reaction Reports of Oxaliplatin
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 645-648.
|
[3] |
ZHENG Sili, ZHANG Xiaoqing.
133 Cases of Adverse Drug Reactions in Female Patients
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 654-658.
|
[4] |
WU Kefei, ZHANG Heng, GUO Chenggang, XU Chunlian, WU Shasha.
Identification of Cremastrae Pseudobulbus/Pleione Pseudobulbus, Adulterants and Commonly-Used Products
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 680-685.
|
[5] |
WANG Hao, MA Jinfu, MA Rui, LI Xiaogang, ZHAO Qiang, ZHANG Xian.
One Case of Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium for Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 686-688.
|
[6] |
MEI Liping, BAI Fuchen, YU Jie, ZHANG Chunjie, WANG Yajun, AN Limei.
Determinants of Blood Drug Concentration / Dose Ratio of Antipsychotics
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 424-428.
|
[7] |
ZOU Yuanlei, XIA Qingrong, LIANG Jun, HE Kongliang, MO Daming, WU Wenning.
Words of Warning and Preventive Measures in Labels of Antidepressants
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 329-333.
|
[8] |
ZHOU Kun, MA Liang, LI Zhaofeng, CAO Bing, GU Hongwei, LIU Qian.
Usage of Nerve-Calming Chinese Herbal Patent Medicines in a Mental Health Center
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 211-216.
|
[9] |
LI Xiaobo, ZHOU Guojian, HUANG Yuling, LI Haiqiao, CHEN Tingting.
One Case of Red Man Syndrome Caused by Locally-Used Low-Dose Vancomycin
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 217-220.
|
[10] |
NIE Xiaolu, SUN Feng, YAN Aixia, PENG Xiaoxia, ZHAN Siyan.
Methodology for Constructing Benchmark Database of Adverse Drug Reactions Based on Multi-Source Information
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 10-15.
|
[11] |
HOU Tiantian, WANG Xudong, YANG Ping, ZHOU Pengbo, QIN Chao, HUANG Ying, WANG Ailing, GENG Xingchao, ZHOU Xiaobing, LIU Defang.
Biodistribution of Therapeutic DNA Vaccines in Mice
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 58-66.
|
[12] |
YU Wenlu, ZHANG Hong.
Research Progress in Applications of Strychnine Semen in Orthopedics and Traumatology
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 116-120.
|
[13] |
YAN Yan, LIU Naiyi, QIAO Ling, ZHANG Yi, YANG Chen.
One case of fulminant type 1 diabetes mellitus induced by allopurinol tablets hypersensitivity syndrome
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1068-1070.
|
[14] |
SHAO Bo, GUO Xiaoxin.
Review of pharmacovigilance of traditional Chinese medicine
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 741-745.
|
[15] |
ZHU Yan, LI Qingna, ZHU Lan, XIE Jiang’an, YAO Keyu, HUANG Guangrui, YANG Xiaolin, GUAN Jian.
Current situation and suggestions concerning the implementation of MedDRA in drug monitoring in China
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 746-751.
|